Cheng E - Search Results

1

Oral piritrexim--a phase II study in patients with advanced soft tissue sarcoma.

Schiesel JD, Carabasi M, Magill G, Casper E, Cheng E, Marks L, Feyzi J, Clendeninn NJ, Smalley RV. Schiesel JD, et al. Among authors: cheng e. Invest New Drugs. 1992 Jul;10(2):97-8. doi: 10.1007/BF00873124. Invest New Drugs. 1992. PMID: 1500271 Clinical Trial. No abstract available.

2

Cisplatin. A phase II evaluation in previously untreated patients with soft tissue sarcomas.

Sordillo PP, Magill GB, Brenner J, Cheng EW, Dosik M, Yagoda A. Sordillo PP, et al. Among authors: cheng ew. Cancer. 1987 Mar 1;59(5):884-6. doi: 10.1002/1097-0142(19870301)59:5<884::aid-cncr2820590504>3.0.co;2-k. Cancer. 1987. PMID: 3815267

3

Phase II trial of cisplatin (CPDD) in previously treated patients with advanced soft tissue sarcoma.

Brenner J, Magill GB, Sordillo PP, Cheng EW, Yagoda A. Brenner J, et al. Among authors: cheng ew. Cancer. 1982 Nov 15;50(10):2031-3. doi: 10.1002/1097-0142(19821115)50:10<2031::aid-cncr2820501010>3.0.co;2-z. Cancer. 1982. PMID: 6889911

4

Phase II trial of menogarol in the treatment of advanced adenocarcinoma of the pancreas.

Sternberg CN, Magill GB, Cheng EW, Hollander P. Sternberg CN, et al. Among authors: cheng ew. Am J Clin Oncol. 1988 Apr;11(2):174-6. doi: 10.1097/00000421-198804000-00017. Am J Clin Oncol. 1988. PMID: 2965856

5

Phase II evaluation of metoprine in advanced pancreatic adenocarcinoma.

Sternberg CN, Magill GB, Sordillo PP, Cheng EW, Kemeny N. Sternberg CN, et al. Among authors: cheng ew. Cancer Treat Rep. 1984 Jul-Aug;68(7-8):1053-4. Cancer Treat Rep. 1984. PMID: 6744341 No abstract available.

6

Adenocarcinoma of unknown primary origin: treatment with vindesine and doxorubicin.

Fiore JJ, Kelsen DP, Gralla RJ, Casper ES, Magill G, Cheng E, Ochoa M Jr. Fiore JJ, et al. Among authors: cheng e. Cancer Treat Rep. 1985 Jun;69(6):591-4. Cancer Treat Rep. 1985. PMID: 4016765

7

Phase II study of 4-demethoxydaunorubicin in patients with adenocarcinoma of the upper gastrointestinal tract.

Einzig A, Kelsen D, Cheng E, Sordillo P, Raymond V, Magill G. Einzig A, et al. Among authors: cheng e. Cancer Treat Rep. 1984 Nov;68(11):1415-6. Cancer Treat Rep. 1984. PMID: 6594197 No abstract available.

8

Phase II trial of idarubicin in patients with pancreatic cancer.

Mittelman A, Magill GB, Raymond V, Sternberg CN, Cheng EW, Sordillo PB, Young CW. Mittelman A, et al. Among authors: cheng ew. Cancer Treat Rep. 1987 Jun;71(6):657-8. Cancer Treat Rep. 1987. PMID: 3472656 No abstract available.

9

MIFA III (mitomycin-C, 5-fluorouracil, and adriamycin) chemotherapy for advanced adenocarcinoma of the pancreas.

Sternberg CN, Magill GB, Sordillo PP, Cheng EW. Sternberg CN, et al. Among authors: cheng ew. Am J Clin Oncol. 1984 Oct;7(5):529-33. doi: 10.1097/00000421-198410000-00027. Am J Clin Oncol. 1984. PMID: 6391145 Clinical Trial.

10

Etoposide (VP-16) in the treatment of advanced adenocarcinoma of the pancreas.

Sternberg CN, Magill GB, Cheng EW, Applewhite A, Sordillo PP. Sternberg CN, et al. Among authors: cheng ew. Am J Clin Oncol. 1988 Apr;11(2):172-3. doi: 10.1097/00000421-198804000-00016. Am J Clin Oncol. 1988. PMID: 3282425 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,538 results

Search Page

Filters